Necitumumab in the Neoadjuvant Setting With Gemcitabine in Surgically Resectable - 14X-US-I001
Stopped Poor accrual
Conditions
- Squamous Cell Lung Cancer
Interventions
- DRUG: Necitumumab-Gemcitabine-Cisplatin
- DIAGNOSTIC_TEST: Evaluation to determine if patient is a candidate to proceeed with surgical resection or not
Sponsor
Montefiore Medical Center
Collaborators